PKM and prostate carcinoma: Interaction between the long non-coding RNA NORAD and miR-541-3p promoted bone metastases in prostate cancer by upregulating the release of EVs enriched with pyruvate kinase M2 (PKM2) from prostate cancer cells to BMSCs [147].